Skip to main content
letter
. 2019 Jun 24;10(11):840–845. doi: 10.1007/s13238-019-0642-z

Table 1.

Clinical and pathological characteristics of the ccRCC patients

Patient No. Gender Age TNM stage Tumor
stage
P#1 male 59 T2N0M0 III
P#2 male 65 T1N0M0 II
P#3 male 48 T2N0M0 II
P#4 male 71 T2N0M0 II
P#5 male 56 T1N0M0 II
P#6 female 64 T2N1M0 III
P#7 male 52 T2N1M0 III
P#8 female 56 T1N0M0 II
P#9 female 59 T1N0M0 II
P#10 male 59 T1N0M0 II
P#11 male 48 T2N0M0 I
P#12 male 45 T1N0M0 II
P#15 male 58 T1N0M0 II
P#16 female 70 T1N0M0 II
P#17 male 49 T1N0M0 II
P#18 male 82 T2N0M0 II
P#19 female 35 T1N0M0 I
P#20 male 44 T1N0M0 II
P#23 male 51 T1N0M0 I
P#25 female 60 T2N0M0 II
P#26 male 61 T1N0M0 I
P#28 male 53 T2N0M1 III
P#29 male 64 T1N0M0 II
P#30 female 69 T1N0M0 II
P#31 male 74 T1N0M0 I
P#32 male 61 T1N0M0 I
P#34 female 56 T1N0MO II
P#35 female 51 T2N0M1 III
P#37 female 76 T1N0M0 II
P#41 female 58 T2N0M1 III
P#43 female 77 T2N1M1 IV
P#44 male 67 T2N0M1 II
P#45 female 48 T3N0M0 II
P#46 male 52 T1N0M0 II
P#47 female 68 T1N0M0 II
P#48 male 29 T1N0M0 II
P#50 female 54 T1N0M0 II
P#51 male 46 T1N0M0 II
P#52 female 53 T1N0M0 III
P#53 male 64 T1N0M1 I
P#54 female 73 T1N0M0 II
P#55 male 70 T1N0M0 III
P#56 male 48 T1N0M0 II
P#57 female 70 T1N0M0 II
P#58 female 75 T1N0M0 II
P#59 female 57 T1N0M0 II
P#60 male 41 T3N0M1 I
P#62 male 48 T1N0M0 II
P#64 female 65 T1N0M0 I
P#65 male 54 T2N0M0 I
P#66 male 50 T3N0M0 III
P#68 male 65 T3N0M0 II
P#69 male 66 T1N0M0 I
P#EX-1 male 44 T1N0M0 II
P#EX-2 female 66 T1N0M0 I
P#EX-3 male 51 T1N0M0 I-II
P#EX-4 female 51 T1N0M0 II
P#EX-5 male 85 T2N1M0 II
P#EX-6 male 35 T1N0M0 II
P#EX-7 male 50 T1N0M0 I
P#EX-8 female 53 T2N0M1 II
P#EX-9 male 61 T2N0M1 II
P#EX-10 male 49 T1N0M0 I
P#EX-11 male 54 T1N0M0 II
P#EX-12 female 60 T2N0M0 II
P#EX-13 male 72 T2n0m0 II
P#EX-14 male 45 T1N0M0 II
P#EX-15 male 52 T1N0MO I
P#EX-16 male 58 T2N0M1 III
P#EX-17 female 67 T2N0M0 II